Form D · Biotechnology
TriSalus Life Sciences, Inc.
Westminster, CO · CIK 0001826667
Offering snapshot reported May 8, 2025 · SEC filing
- Reported sold
- $22M Offering amount: $22M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 2, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2025 | Initial | $22,000,000 | No comparison | 24 | SEC filing |
| Dec 30, 2024 | Initial | $999,984 | No comparison | 6 | SEC filing |
| Jun 22, 2023 | Initial | $17,855,020 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545575
Source: Form D, filed May 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Manuel Aguero | Director |
| Bryan F. Cox | Executive |
| Brian Cox | Executive |
| Arjun Desai | Director |
| Jodi Devlin | Executive |
| Christopher C. Dewey | Director, Executive |
| Gary Gordon | Director |
| Kerry Hicks | Director |
| Liselotte Hyveled | Director |
| Karim Karti | Director |
| Richard Marshak | Executive |
| George Kelly Martin | Director |
| David J. Matlin | Director |
| Sean Murphy | Director |
| Martin Roche | Director |
| Jennifer Stevens | Executive |
| Mary Szela | Director, Executive |
| Thierry Thaure | Director |
| David L. Treadwell | Director |
| William F. Valle | Director |
| Andrew Von Eschenbach | Director |
| Mats Wahlstrom | Director |
| Robert H. Weiss | Executive |
| James Young | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6272 West 91 St Avenue
Westminster, CO, 80031
Westminster, CO, 80031